Trial intelligence / Profile preview

Short-term Depo-Provera in Endometrial Cancer

NCT00064025Phase 2Completed

Sponsor
GOG Foundation
Start
Apr 2004
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of medroxyprogesterone acetate in endometrial adenocarcinoma, sponsored by GOG Foundation. Started Apr 2004; status: completed.

02

Drugs

medroxyprogesterone acetate
03

Conditions

endometrial adenocarcinoma

Beyond the preview

Go deeper on NCT00064025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00064025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call